Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a $150,000 UT Science and Technology Acquisition and Retention (STARs) award from the […]
Share This Story
Alicia Logue, MD, associate professor, Department of Surgery, was quoted in this article. Read More
Share This Story
Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source. Listen Now
Share This Story
Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation, bringing new hope for survival.
Share This Story
Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this news segment. Watch Now
Share This Story
Sukeshi Patel Arora, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, participated in a live in-studio interview for this news segment. Watch Now
Share This Story
Sukeshi Patel Arora, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, participated in a live in-studio interview for this news segment. Watch Now
Share This Story
New hope for adult sufferers of most common primary brain tumor A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults. Results of a trial led by the university revealed that […]
Share This Story
Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is proud to announce the American Cancer Society’s continued support for its lung cancer screening program. The gift is a $30,000 contribution to UT Health San Antonio’s Primary Care Center locations to appoint a lung cancer screening navigator and […]
Share This Story
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that […]
Share This Story